For flibanserin to be marketed Pharmacy Journal, it must still be approved by the Food and Drug Administration, but it usually follows the experts’ recommendations. A final decision is due August 18.
For flibanserin to be marketed Pharmacy Journal, it must still be approved by the Food and Drug Administration, but it usually follows the experts’ recommendations. A final decision is due August 18.